Evidence map›Paper›PMID 16944252›Full record

ReviewJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2006

Potential benefits and limitations of various strategies to mitigate the impact of an influenza pandemic.

Hitoshi Oshitani

Abstract readReview
In one paragraph

Review in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2007
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Prevention of influenza at Hajj: applications for mass gatherings.Journal of the Royal Society of Medicine · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The open-air treatment of pandemic influenza.American journal of public health · 2009
    Article
  15. Review
  16. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2008
    Article
  17. Virtual epidemic in a virtual city: simulating the spread of influenza in a US metropolitan area.Translational research : the journal of laboratory and clinical medicine · 2008
    Article
  18. Transmission of influenza A in human beings.The Lancet. Infectious diseases · 2007
    Article
  19. Pandemic influenza planning in nursing homes: are we prepared?Journal of the American Geriatrics Society · 2007
    Review
  20. Nonpharmaceutical Interventions for Military Populations During Pandemic Influenza.Turk Silahli Kuvvetleri koruyucu hekimlik bulteni · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hitoshi OshitaniTohoku University Graduate School of Medicine, Department of Virology, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. oshitanih@mail.tains.tohoku.ac.jp

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent avian influenza outbreaks underscore the importance of improving our preparedness for an impending influenza pandemic. Various strategies, including pharmaceutical interventions (such as vaccines and antivirals) and nonpharmaceutical interventions (such as quarantine, isolation, and social distancing) may be implemented to mitigate the impact of a pandemic. It is necessary to understand the potential benefits and limitations of each strategy to determine the most appropriate strategies to be implemented. In this article, each strategy is reviewed to define its potential benefits and limitations during a pandemic. Vaccines are probably the most effective measure to reduce morbidity and mortality. However, vaccines are not likely to be available at an early stage of a pandemic. The supply of vaccines is most likely to be insufficient due to limited worldwide production capacity. Antivirals, particularly neuraminidase inhibitors, are expected to be effective against a pandemic influenza strain and are the only available pharmaceutical intervention until enough vaccines are produced. Shortage of supply and high cost is still a major limiting factor in amassing large stockpiles of neuraminidase inhibitors. The possible emergence of resistant strains should also be considered. Nonpharmaceutical interventions can be effective in preventing the spread of the virus under certain conditions. The effectiveness of nonpharmaceutical interventions depends on how influenza viruses are transmitted. There are still significant gaps in the scientific evidence of the way in which influenza viruses are transmitted. Further studies should be conducted to define the basic transmission patterns of influenza viruses.

Indexed as

Antiviral AgentsDisease OutbreaksHumansInfluenza, HumanInfluenza VaccinesAntiviral AgentsInfluenza Vaccines

Identifiers

PMID16944252
PMCPMC7088021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.